Xiong Guo Selected Research

Hydronephrosis

1/2021	Assessment of the Contrast-Enhanced Ultrasound in Percutaneous Nephrolithotomy for the Treatment of Patients with Nondilated Collecting System.
4/2020	Ceftazidime-related urinary calculi in a young boy: a case report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Xiong Guo Research Topics

Disease

72	Kashin-Beck Disease 10/2022 - 01/2006
31	Osteoarthritis 04/2022 - 01/2006
17	Neoplasms (Cancer) 01/2022 - 03/2015
10	Osteoporosis 01/2019 - 03/2005
8	Stomach Neoplasms (Stomach Cancer) 01/2022 - 11/2019
6	Keshan disease 11/2019 - 05/2017
5	Intervertebral Disc Degeneration 10/2016 - 01/2005
4	Carcinogenesis 01/2022 - 01/2018
4	Colorectal Neoplasms (Colorectal Cancer) 01/2021 - 01/2017
4	Necrosis 01/2018 - 01/2013
3	Hypoxia (Hypoxemia) 01/2021 - 01/2010
3	Wounds and Injuries (Trauma) 10/2020 - 05/2016
3	Rheumatoid Arthritis 03/2020 - 01/2017
3	Neoplasm Metastasis (Metastasis) 01/2020 - 07/2016
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 11/2017
3	Inflammation (Inflammations) 05/2019 - 11/2015
3	Intervertebral Disc Displacement (Herniated Disc) 11/2013 - 01/2013
2	Kidney Calculi (Kidney Stone) 01/2021 - 04/2020
2	Hydronephrosis 01/2021 - 04/2020
2	Osteonecrosis (Kienbock's Disease) 01/2021 - 07/2015
2	Cicatrix (Scar) 10/2020 - 07/2015
2	Pain (Aches) 09/2020 - 11/2013
2	Joint Diseases (Joint Disease) 02/2020 - 01/2020
2	Alcoholism (Alcohol Abuse) 01/2020 - 01/2019
2	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 04/2019
2	Knee Osteoarthritis 09/2019 - 07/2005
2	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2019 - 11/2018
2	Cataract (Cataracts) 01/2018 - 01/2018
2	Fibrosis (Cirrhosis) 02/2017 - 11/2015
2	Bone Fractures (Bone Fracture) 10/2015 - 06/2012
2	Mitochondrial Diseases (Mitochondrial Disease) 01/2014 - 12/2012
1	Poisoning 03/2022
1	Myocardial Infarction 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Lung Neoplasms (Lung Cancer) 12/2021
1	Melanoma (Melanoma, Malignant) 12/2021
1	Postoperative Hemorrhage 01/2021

Drug/Important Bio-Agent (IBA)

30	SeleniumIBA 10/2022 - 07/2008
13	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2008
12	T-2 Toxin (T 2 Toxin)IBA 03/2022 - 02/2013
12	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2014
11	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2008
9	Circular RNAIBA 01/2022 - 01/2019
8	Biological ProductsIBA 10/2022 - 07/2015
8	Long Noncoding RNAIBA 01/2022 - 12/2017
7	Messenger RNA (mRNA)IBA 01/2022 - 01/2018
7	RNA (Ribonucleic Acid)IBA 01/2022 - 09/2018
6	Hyaluronic Acid (Hyaluronan)IBA 03/2020 - 07/2005
6	CollagenIBA 04/2018 - 02/2008
5	MycotoxinsIBA 03/2022 - 07/2012
5	EnzymesIBA 12/2021 - 10/2017
5	Chondroitin Sulfates (Chondroitin Sulfate)IBA 12/2021 - 02/2013
4	CateninsIBA 09/2020 - 12/2017
4	SaltsIBA 09/2019 - 03/2006
4	CytokinesIBA 11/2016 - 08/2006
4	Tretinoin (Retinoic Acid)FDA LinkGeneric 09/2007 - 03/2005
3	Glycoproteins (Glycoprotein)IBA 04/2022 - 05/2017
3	ZincIBA 01/2022 - 10/2017
3	Collagen Type I (Type I Collagen)IBA 10/2020 - 07/2008
3	MagnesiumIBA 11/2019 - 02/2013
3	Capsules (Microcapsules)IBA 01/2018 - 02/2006
3	CalciumIBA 01/2018 - 09/2007
3	Therapeutic UsesIBA 01/2013 - 12/2006
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2010 - 01/2006
2	IodineIBA 10/2022 - 03/2016
2	Tissue Inhibitor of Metalloproteinase-1IBA 02/2022 - 01/2022
2	Selenoproteins (Selenoprotein)IBA 02/2022 - 01/2020
2	LuciferasesIBA 12/2021 - 01/2020
2	Paclitaxel (Taxol)FDA LinkGeneric 12/2021 - 03/2015
2	Death Domain ReceptorsIBA 12/2021 - 11/2011
2	Aggrecans (Aggrecan)IBA 12/2021 - 03/2018
2	SulfotransferasesIBA 03/2020 - 03/2020
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2020 - 01/2006
2	beryllium oxideIBA 04/2019 - 07/2015
2	Pharmaceutical PreparationsIBA 01/2019 - 03/2005
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 07/2012 - 07/2007
2	Alkaline PhosphataseIBA 01/2010 - 09/2007
2	GalliumIBA 09/2007 - 03/2006
2	gallium chlorideIBA 09/2007 - 03/2006
1	IronIBA 10/2022
1	ManganeseIBA 10/2022
1	fulvic acidIBA 03/2022
1	Matrix Metalloproteinases (MMPs)IBA 01/2022
1	Immune Checkpoint InhibitorsIBA 01/2022
1	Heparan Sulfate Proteoglycans (Heparan Sulfate Proteoglycan)IBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	Branched-Chain Amino AcidsIBA 01/2022
1	Glutathione (Reduced Glutathione)IBA 12/2021
1	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2021
1	Competitive Endogenous RNAIBA 01/2021

Therapy/Procedure

6	Therapeutics 01/2022 - 07/2005
4	Immunotherapy 01/2022 - 01/2020
3	Intra-Articular Injections 03/2020 - 07/2005
3	Diskectomy (Discectomy) 11/2015 - 11/2013
2	Laminectomy 07/2015 - 01/2013
2	Replantation 11/2013 - 01/2013
2	Osteotomy 11/2013 - 01/2013
1	Intravenous Injections 12/2021
1	Length of Stay 01/2021
1	Punctures 01/2021